Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751998 · ClinicalTrials.gov registry record
Spy II Clinical Registry
A clinical trial of Biliary Tract Diseases, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 297
- Enrollment target
- 15
- Study locations
NCT00751998: Completed study of Biliary Tract Diseases, sponsored by Boston Scientific Corporation.
NCT00751998 is a study of Biliary Tract Diseases that has completed, run by Boston Scientific Corporation. The registered enrollment target is 297 participants. The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00751998, a study of Biliary Tract Diseases, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
- 15
- Study locations
Study Summary
A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
Conditions Studied
Interventions
- DEVICE SpyGlass
Study Locations (15)
Other
- Erasme Hospital - Belgium - Brussels
- Bispebjerg Hospital, Denmark - København NV
- Hopital Edouard Herriot - Lyon
- Evangelisches Krankenhaus Dusseldorf - Düsseldorf
- Policlinico Agostino Gemelli - Roma
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
- University of Pittsburgh - Pittsburgh
California
- California Pacific Medical Center - San Francisco
Colorado
- University of Colorado Hospital - Aurora
Indiana
- Indiana University Medical Center - Indianapolis
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-10 |
What the finished NCT00751998 record still lists
NCT00751998 is an observational study that tracks outcomes without assigning an intervention. The registered 297 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Biliary Tract Diseases appearing as the primary indexed condition, and to 1 intervention - of which SpyGlass is the first listed.
NCT00751998 lists 15 locations in 10 states (Other, Pennsylvania, California).
Frequently Asked Questions
What is clinical trial NCT00751998 about?
NCT00751998 is a clinical study titled "Spy II Clinical Registry". A prospective, multi-center registry for subjects undergoing Endoscopic retrograde Cholangiopancreatography (ERCP) and cholangioscopy for known or suspected pancreaticobiliary disease.
What is the current status of trial NCT00751998?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2006-11. Estimated completion is 2009-10.
What conditions does trial NCT00751998 study?
This clinical trial studies the following conditions: Biliary Tract Diseases.
What interventions are being tested in trial NCT00751998?
The interventions under investigation include: SpyGlass (DEVICE).
Who is sponsoring clinical trial NCT00751998?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00751998 being conducted?
This trial has 15 study locations across California, Colorado, Indiana, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Tract Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
- NCT06375811 · 297 participants · Phase 3
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- NCT07222215 · 297 participants · Phase 2
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia